Search - tctmd.com

Displaying 221 - 240 of 1417

Sort: Relevancy | Date

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

Presenter: Robert Smith

October 15, 2020

Presentation TCT 2020

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Presenter: Benjamin Peterson

October 15, 2020

Presentation TCT 2020

TCT ID 2: The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation – Day Outcomes From the CLASP TR Early Feasibility Study

Presenter: Charles Davidson

October 15, 2020

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

Presentation TCT 2020

Temporary Spur Stent System for PVD Interventions (ReFlow)

Presenter: Jihad Mustapha

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

Presentation TCT 2020

Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Presenter: Junjie Zhang

October 15, 2020

Presentation TCT 2020

Keynote Lecture: Key Advances in RDN for HTN

Presenter: Felix Mahfoud

October 15, 2020

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

Presentation TCT 2020

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

Presenter: Michel Bosiers

October 15, 2020

Presentation TCT 2020

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

Presenter: Roxana Mehran

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

Presentation TCT 2020

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Presenter: Dean J. Kereiakes

October 15, 2020

Presentation TCT 2020

Catheter-Based Approach to Cardio Renal Unloading in HF (preCARDIA)

Presenter: Navin Kapur

October 15, 2020

Presentation TCT 2020

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

Presenter: Philipp Lurz

October 15, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

Presentation TCT 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

Transcatheter Tricuspid Valve Replacement 2.0 (VDyne)

Presenter: Azeem Latib

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Advertisement

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

TCT ID 2: The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation – Day Outcomes From the CLASP TR Early Feasibility Study

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Temporary Spur Stent System for PVD Interventions (ReFlow)

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Keynote Lecture: Key Advances in RDN for HTN

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study

Catheter-Based Approach to Cardio Renal Unloading in HF (preCARDIA)

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Transcatheter Tricuspid Valve Replacement 2.0 (VDyne)

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content